SLRN - ACELYRIN, Inc.
2.27
0.040 1.762%
Share volume: 4,076,542
Last Updated: 05-20-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$2.23
0.04
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-13-2024 | 03-19-2025 | 05-14-2025 | |
| Assets | ||||||
| Total Assets | 697.484 M | 651.739 M | 618.310 M | 491.141 M | 436.504 M | |
| Current Assets | 693.981 M | 648.261 M | 596.589 M | 480.987 M | 429.492 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 414.037 M | 507.029 M | 346.047 M | 373.990 M | 352.321 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 264.501 M | 128.211 M | 216.326 M | 73.890 M | 58.271 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 2.179 M | 1.509 M | 1.700 M | 1.635 M | 452.000 K | |
| Other Assets | 1.324 M | 1.969 M | 20.021 M | 8.519 M | 6.560 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 697.484 M | 651.739 M | 618.310 M | 491.141 M | 436.504 M | |
| Total liabilities | 53.417 M | 83.521 M | 90.029 M | 32.848 M | 29.273 M | |
| Total current liabilities | 52.283 M | 82.452 M | 83.471 M | 26.578 M | 23.303 M | |
| Accounts Payable | 9.994 M | 40.722 M | 17.550 M | 4.888 M | 9.932 M | |
| Other liabilities | 1.134 M | 1.069 M | 6.558 M | 6.270 M | 5.970 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 1.134 M | 1.069 M | 6.558 M | 6.270 M | 5.970 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 644.067 M | 568.218 M | 528.281 M | 458.293 M | 407.231 M | |
| Common stock | 1.168 B | 1.178 B | 1.186 B | 1.195 B | 1.199 B | |
| Retained earnings | -523.692 M | -609.364 M | -657.912 M | -736.945 M | -792.209 M |